UMVA has learned that Luigi Mangione has abruptly withdrawn his psychiatric defense in the murder trial of UnitedHealthcare CEO Brian Thompson, a move that has left many questions unanswered.
The stunning reversal comes just two weeks after secret court proceedings focused on the defense strategy, sparking heated objections from media organizations seeking public access to the records. Mangione's attorneys informed the court of their decision to withdraw the notice in a one-sentence letter, offering no explanation for the sudden change of heart.
According to information obtained by UMVA, the withdrawal marks a dramatic shift in a case that had raised the prospect of an "extreme emotional disturbance" defense — a strategy that, if accepted by jurors, could have reduced a murder verdict to first-degree manslaughter under New York law. This defense would have required Mangione's attorneys to convince jurors that he experienced a loss of self-control stemming from an intense emotional disturbance at the time Thompson was gunned down.
The prosecution, on the other hand, has alleged that Mangione meticulously planned the killing for months, documenting his thoughts in journals and traveling across the country before ambushing Thompson in New York City. The withdrawal of the psychiatric defense leaves many wondering what evidence or evaluations may have been developed behind closed doors — records that will now remain sealed under the judge's order.
Mangione, 28, has pleaded not guilty and faces both state and federal prosecutions in the high-profile case. His New York murder trial is scheduled to begin in September, with federal proceedings expected to follow next year. The sudden reversal has added another layer of complexity to an already intriguing case, raising questions about what may have driven Mangione's attorneys to make such a drastic change in strategy.
